Evidence map›Paper›PMID 32185287›Full record

ArticleMediterranean journal of rheumatology2017

Rituximab and lenalidomide combination treatment for rheumatoid arthritis complicated with myelodysplastic syndrome: A case report.

Gerasimos Evangelatos, Ioanna Vlachadami, Maria Kechagia, Alexios Iliopoulos

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Mediterranean journal of rheumatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Mediterranean Journal of Rheumatology December 2017 Highlights.Mediterranean journal of rheumatology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Gerasimos EvangelatosRheumatology Department, 417 Army Share Fund Hospital (NIMTS), Athens, Greece.
Ioanna VlachadamiDepartment of Pathophysiology, General Hospital of Athens "Laiko", Athens, Greece.
Maria KechagiaRheumatology Department, 417 Army Share Fund Hospital (NIMTS), Athens, Greece.
Alexios IliopoulosRheumatology Department, 417 Army Share Fund Hospital (NIMTS), Athens, Greece.
NIMTS Hospital · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rheumatoid arthritis patients might experience several hematologic complications. The development of myelodysplastic syndrome is not clearly associated with RA, even though it has been described in some patients with pre-existing disease. There are only few data available in the literature concerning the therapeutic approach of such patients. Herein, we report a case of RA complicated with progressive MDS, successfully treated with rituximab and lenalidomide combination therapy.

Indexed as

lenalidomidemyelodysplastic syndromerheumatoid arthritisrituximab

Identifiers

PMID32185287
PMCPMC7045997
OpenAlexW2900912891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.